Make your action matter by taking the $31 Challenge!
March is Myeloma Action Month. Join us - take action by donating $31, one dollar for each day in March.
Give one dollar (or more!) for each day during Myeloma Action Month. Your donation supports the International Myeloma Foundation's ongoing work - improving lives and finding the cure! (Source: International Myeloma Foundation)
Source: International Myeloma Foundation - March 1, 2016 Category: Hematology Source Type: news
Consumers of Medical News Need to Be Wary and Aware
A bounty of medical news and information is increasingly available online. However, as IMF Chairman Dr. Brian Durie writes in his blog this week, it's important to digest medical news with a critical eye. Dr. Durie examines two recent topics in the news that he says bear deeper scrutiny: the Zika virus and the crowdfunding of myeloma clinical trials. To read Dr. Durie's blog, click HERE. (Source: International Myeloma Foundation)
Source: International Myeloma Foundation - February 26, 2016 Category: Hematology Source Type: news
International Myeloma Foundation (IMF) Declares March Myeloma Action Month
IMF’s Proactive Education Campaign Targets Primary Care Doctors, Lawmakers and Patients with Information and Events (Source: International Myeloma Foundation)
Source: International Myeloma Foundation - February 18, 2016 Category: Hematology Source Type: news
Register NOW for FREE IMF Regional Community Workshops
The IMF's Regional Community Workshops are free half-day meetings that allow the IMF to expand the reach of this program to a wider audience. Upcoming Regional Community Workshops will take place in Cleveland, Ohio on March 5, 2016 and in Denver, Colorado on April 2, 2016. The Cleveland workshop features panelists Craig Emmitt Cole, M.D.; Craig Hofmeister, M.D., MPH; and Beth Faiman, PhD, MSN, APRN-BC, AOCN. And the Denver workshop includes the panelists Craig Emmitt Cole, M.D.; Dr. Jeffrey V. Matous, MD; and Sandra Rome, RN, MN, AOCN. Registration is FREE, but seating is limited. To register for either workshop, click HER...
Source: International Myeloma Foundation - February 16, 2016 Category: Hematology Source Type: news
IMF Mourns Passing of Pat Killingsworth, Respected Patient Advocate
-- myeloma patient advocate and "Beacon" of light for the entire myeloma community (Source: International Myeloma Foundation)
Source: International Myeloma Foundation - February 12, 2016 Category: Hematology Source Type: news
Have Researchers Found What Might Cause Myeloma?
Yale Cancer Center researchers published the findings from a study this week in the New England Journal of Medicine showing that chronic stimulation of the immune system by lipids made in the context of inflammation underlies the origins of some myeloma cases. “Although this is interesting and illustrative, it is not identifying what causes myeloma overall,” writes IMF Chairman Dr. Brian Durie in his blog this week. To read Dr. Durie's blog, click HERE. (Source: International Myeloma Foundation)
Source: International Myeloma Foundation - February 11, 2016 Category: Hematology Source Type: news
Clearing the Decks for Deep Thinking Is Vital in Science
Collaboration has fueled many achievements made by the IMF and the International Myeloma Working Group (IMWG). But scientific advances also come from the kind of “deep thinking” that there is little time for in today's hectic world. In his blog this week, IMF Chairman Dr. Brian Durie explores why both types of settings are important to push the research needle forward. To read Dr. Durie's blog, click HERE. (Source: International Myeloma Foundation)
Source: International Myeloma Foundation - February 5, 2016 Category: Hematology Source Type: news
European Medicines Agency Pushes for Empliciti for the Treatment of Multiple Myeloma
The Committee for Medicinal Products for Human Use (CHMP) reviewed the monoclonal antibody Empliciti® (elotuzumab) as part of the European Medicine Agency's (EMA) accelerated assessment program. After review, CHMP recommended that Empliciti® should be used in combination with lenalidomide and dexamethasone for multiple myeloma patients who have received at least one prior therapy. This EMA recommendation will be sent to the European Commission of the European Union, the body that will make the final decision on authorizing the marketing of Empliciti®'s use. To learn more, click HERE. (Source: International Myeloma Foundation)
Source: International Myeloma Foundation - February 4, 2016 Category: Hematology Source Type: news
Boston Celtics Sink Baskets and Donations to the IMF
The International Myeloma Foundation is thrilled to announce that this NBA season, the organization's research and education programs will be the winners in Takeda Oncology's new campaign “3 Points for Patients.” Each time one of the 17-time champion Boston Celtics sinks a 3-point basket during the regular NBA season, Takeda Oncology will make a donation to the IMF. With the high-scoring Celtics' track record, that could result in an additional $25,000 to support the IMF. Learn more from this video with Celtics' Head Coach Brad Stevens. (Source: International Myeloma Foundation)
Source: International Myeloma Foundation - February 1, 2016 Category: Hematology Source Type: news
Getting Serious -and Silly- About Healthy Eating
We humans are obsessed with and confused by food. In his blog this week, IMF Chairman Dr. Brian Durie considers two recently published books that illustrate both ends of the spectrum. “I'll Have What She's Having: My Adventures in Celebrity Dieting” is a wry look at the eating habits of the fit and famous (Gwyneth Paltrow, Elizabeth Taylor, Beyoncé). “Fat Chance” is a more serious examination of the real dangers of sugar and processed foods. To read Dr. Durie's blog, click HERE. (Source: International Myeloma Foundation)
Source: International Myeloma Foundation - January 29, 2016 Category: Hematology Source Type: news
FDA Approves New Kyprolis & #174; (carfilzomib) combination therapy for the treatment of patients with RRMM.
Kyprolis Label Expansion Represents Critical Advancement for Patients With Relapsed or Refractory Multiple Myeloma, Offering New Option For Backbone Therapy. Approval Expands Kyprolis Indication and Converts Monotherapy Indication to Full Approval. (Source: International Myeloma Foundation)
Source: International Myeloma Foundation - January 25, 2016 Category: Hematology Source Type: news
FDA Approves New Kyprolis® (carfilzomib) combination therapy for the treatment of patients with RRMM.
Kyprolis Label Expansion Represents Critical Advancement for Patients With Relapsed or Refractory Multiple Myeloma, Offering New Option For Backbone Therapy. Approval Expands Kyprolis Indication and Converts Monotherapy Indication to Full Approval. (Source: International Myeloma Foundation)
Source: International Myeloma Foundation - January 25, 2016 Category: Hematology Source Type: news
The Black Swan Research Initiative & #174; Is the “Myeloma Moonshot”
Many of the approaches to curing cancer Vice President Joe Biden advocates as part of the much-discussed “cancer moonshot” have been part of the IMF's Black Swan Research Initiative since its launch in 2012. In his blog this week, IMF Chairman Dr. Brian Durie says that collaboration and putting an end to research “silos” promise to bring us closer to a cure for myeloma. To read Dr. Durie's blog , click HERE. (Source: International Myeloma Foundation)
Source: International Myeloma Foundation - January 22, 2016 Category: Hematology Source Type: news
The Black Swan Research Initiative® Is the “Myeloma Moonshot”
Many of the approaches to curing cancer Vice President Joe Biden advocates as part of the much-discussed “cancer moonshot” have been part of the IMF's Black Swan Research Initiative since its launch in 2012. In his blog this week, IMF Chairman Dr. Brian Durie says that collaboration and putting an end to research “silos” promise to bring us closer to a cure for myeloma. To read Dr. Durie's blog, click HERE. (Source: International Myeloma Foundation)
Source: International Myeloma Foundation - January 22, 2016 Category: Hematology Source Type: news
Register Now for the IMF's Free Regional Community Workshop in Cleveland
The IMF hosts “Living Successfully with Multiple Myeloma,” a Regional Community Workshop, at the InterContinental Hotel in Cleveland, Ohio on Saturday, March 5, 2016. This workshop provides education on such topics as myeloma basics, novel therapies, side effects management, and supportive care issues. The panelists include Drs. Craig Emmitt Cole (University of Michigan), Craig Hofmeister (Ohio State University), and Beth Faiman, PhD, MSN (Cleveland Clinic Taussig Cancer Institute). Registration is FREE, but seating is limited. To register, call 800-452-CURE (2873) or click HERE. (Source: International Myeloma Foundation)
Source: International Myeloma Foundation - January 21, 2016 Category: Hematology Source Type: news
